Tapewire

NYSE · USD

ZBH

ZIMMER BIOMET HOLDINGS, INC.

Export transactions ↓
Tapewire entity
3278
SEC CIK
0001136869
Parsed reports
830

Last 12 months

Inside the activity.

0 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202601
Mar 202601
Apr 202600
May 202602
Jun 202600
Jul 202600
Aug 202600
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 10, 2019 Filed May 14, 2019 21:25 UTC GrantPhantom Stock Units · Derivative 500 $0.00 Strike: $120.58 $0.00
Disclosure

SEC source: 0000911916-19-000113 · edgar.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,820.567

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 35.558 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 10, 2019 Filed May 14, 2019 21:23 UTC GrantRestricted Stock Units · Derivative 1,078.122 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000110 · edgar.xml · derivative · entry 2

BOUDREAUX GAIL · CIK 0001287920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,363.881

Underlying: Common Stock · 1,078.122 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 10, 2019 Filed May 14, 2019 21:23 UTC GrantPhantom Stock Units · Derivative 500 $0.00 Strike: $120.58 $0.00
Disclosure

SEC source: 0000911916-19-000110 · edgar.xml · derivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,490.032

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 17.300 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 10, 2019 Filed May 14, 2019 21:24 UTC GrantRestricted Stock Units · Derivative 1,078.122 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000112 · edgar.xml · derivative · entry 2

GLASSCOCK LARRY C · CIK 0001189793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,467.934

Underlying: Common Stock · 1,078.122 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of the Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 10, 2019 Filed May 14, 2019 21:24 UTC GrantPhantom Stock Units · Derivative 500 $0.00 Strike: $120.58 $0.00
Disclosure

SEC source: 0000911916-19-000112 · edgar.xml · derivative · entry 1

GLASSCOCK LARRY C · CIK 0001189793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,693.237

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of the Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 172.336 phantom stock units accrued between July 31, 2018 and April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 10, 2019 Filed May 14, 2019 21:23 UTC GrantRestricted Stock Units · Derivative 1,078.122 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000111 · edgar.xml · derivative · entry 2

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,596.778

Underlying: Common Stock · 1,078.122 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 10, 2019 Filed May 14, 2019 21:23 UTC GrantPhantom Stock Units · Derivative 500 $0.00 Strike: $120.58 $0.00
Disclosure

SEC source: 0000911916-19-000111 · edgar.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,362.609

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 11.154 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 10, 2019 Filed May 14, 2019 21:21 UTC GrantRestricted Stock Units · Derivative 1,078.122 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000107 · edgar.xml · derivative · entry 2

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,363.881

Underlying: Common Stock · 1,078.122 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 10, 2019 Filed May 14, 2019 21:21 UTC GrantPhantom Stock Units · Derivative 500 $0.00 Strike: $120.58 $0.00
Disclosure

SEC source: 0000911916-19-000107 · edgar.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,152.912

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 18.351 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 10, 2019 Filed May 14, 2019 21:22 UTC GrantRestricted Stock Units · Derivative 1,078.122 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000109 · edgar.xml · derivative · entry 2

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,022.258

Underlying: Common Stock · 1,078.122 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 10, 2019 Filed May 14, 2019 21:22 UTC GrantPhantom Stock Units · Derivative 500 $0.00 Strike: $120.58 $0.00
Disclosure

SEC source: 0000911916-19-000109 · edgar.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,292.638

Underlying: Common Stock · 500 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 20.784 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 08, 2019 Filed Jun 20, 2019 20:51 UTC
Florin Daniel PExec. VP, CFO
GiftCommon Stock 239 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000137 · edgar.xml · nonDerivative · entry 1

Florin Daniel P · CIK 0001402459 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,471

F1 · kind: This transaction involved a gift of securities by the reporting person and is being voluntarily reported earlier than required.

Read SEC document
May 03, 2019 Filed May 7, 2019 20:18 UTC
Tornos IvanGroup President, Orthopedics
Exercise / conversionRestricted Stock Units · Derivative 8,140 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000105 · edgar.xml · derivative · entry 3

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,140 shares

Expires 2019-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

Read SEC document
May 03, 2019 Filed May 7, 2019 20:18 UTC
Tornos IvanGroup President, Orthopedics
Tax withholdingCommon Stock 2,834 $124.30 $352,266.20
Disclosure

SEC source: 0000911916-19-000105 · edgar.xml · nonDerivative · entry 2

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,306

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units.

Read SEC document
May 03, 2019 Filed May 7, 2019 20:18 UTC
Tornos IvanGroup President, Orthopedics
Exercise / conversionCommon Stock 8,140 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000105 · edgar.xml · nonDerivative · entry 1

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,140

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 31, 2019 Filed Apr 2, 2019 23:04 UTC GrantPhantom Stock Units · Derivative 186.67 $0.00 Strike: $127.23 $0.00
Disclosure

SEC source: 0000911916-19-000103 · edgar.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,913.9

Underlying: Common Stock · 186.67 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: 93.335 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: 93.335 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 9.901 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2019 Filed Apr 2, 2019 23:00 UTC GrantPhantom Stock Units · Derivative 216.144 $0.00 Strike: $127.23 $0.00
Disclosure

SEC source: 0000911916-19-000097 · edgar.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,771.854

Underlying: Common Stock · 216.144 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 22.652 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2019 Filed Apr 2, 2019 23:04 UTC GrantPhantom Stock Units · Derivative 216.144 $0.00 Strike: $127.23 $0.00
Disclosure

SEC source: 0000911916-19-000101 · edgar.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,897.238

Underlying: Common Stock · 216.144 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 49.345 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2019 Filed Apr 2, 2019 23:00 UTC GrantPhantom Stock Units · Derivative 314.695 $0.00 Strike: $127.23 $0.00
Disclosure

SEC source: 0000911916-19-000096 · edgar.xml · derivative · entry 2

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,634.561

Underlying: Common Stock · 314.695 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F4 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
March 31, 2019 Filed Apr 2, 2019 23:04 UTC GrantPhantom Stock Units · Derivative 186.67 $0.00 Strike: $127.23 $0.00
Disclosure

SEC source: 0000911916-19-000102 · edgar.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 598.522

Underlying: Common Stock · 186.67 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: 93.335 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: 93.335 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes .401 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2019 Filed Apr 2, 2019 23:03 UTC GrantPhantom Stock Units · Derivative 225.969 $0.00 Strike: $127.23 $0.00
Disclosure

SEC source: 0000911916-19-000100 · edgar.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,285.009

Underlying: Common Stock · 225.969 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 39.144 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2019 Filed Apr 2, 2019 23:03 UTC GrantPhantom Stock Units · Derivative 186.67 $0.00 Strike: $127.23 $0.00
Disclosure

SEC source: 0000911916-19-000099 · edgar.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,851.455

Underlying: Common Stock · 186.67 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 11.965 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2019 Filed Apr 2, 2019 23:01 UTC GrantPhantom Stock Units · Derivative 186.67 $0.00 Strike: $127.23 $0.00
Disclosure

SEC source: 0000911916-19-000098 · edgar.xml · derivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,972.732

Underlying: Common Stock · 186.67 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 18.836 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2019 Filed Apr 2, 2019 21:28 UTC GrantPhantom Stock Units · Derivative 93.335 $0.00 Strike: $127.23 $0.00
Disclosure

SEC source: 0000911916-19-000094 · edgar.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 299.262

Underlying: Common Stock · 93.335 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes .201 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 29, 2019 Filed Apr 2, 2019 23:00 UTC GrantPhantom Stock Units · Derivative 98.551 $0.00 Strike: $115.47 $0.00
Disclosure

SEC source: 0000911916-19-000096 · edgar.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,319.866

Underlying: Common Stock · 98.551 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · shares: Represents phantom stock units credited to the reporting person under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors, as units earned but not credited for committee chair fees in 2018 and related units for dividend payments following the date the units were earned.

F4 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.underlying_shares: Represents phantom stock units credited to the reporting person under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors, as units earned but not credited for committee chair fees in 2018 and related units for dividend payments following the date the units were earned.

F5 · balance_after: Includes 19.794 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 20, 2019 Filed Mar 22, 2019 20:15 UTC
Yi SangPresident, Asia Pacific
Exercise / conversionRestricted Stock Units · Derivative 1,443 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000084 · edgar.xml · derivative · entry 2

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,443 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: Earned RSUs vested on March 20, 2019.

F3 · derivative.expiration_date: Earned RSUs vested on March 20, 2019.

Read SEC document
March 20, 2019 Filed Mar 22, 2019 20:15 UTC
Yi SangPresident, Asia Pacific
Exercise / conversionCommon Stock 1,443 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000084 · edgar.xml · nonDerivative · entry 1

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,883

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 426 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between June 30, 2017 and December 31, 2018.

Read SEC document
March 20, 2019 Filed Mar 22, 2019 20:14 UTC
Phipps Chad FSr. VP/Gen Counsel/Secretary
Exercise / conversionRestricted Stock Units · Derivative 1,331 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000082 · edgar.xml · derivative · entry 3

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,331 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: Earned RSUs vested on March 20, 2019.

F4 · derivative.expiration_date: Earned RSUs vested on March 20, 2019.

Read SEC document
March 20, 2019 Filed Mar 22, 2019 20:14 UTC
Phipps Chad FSr. VP/Gen Counsel/Secretary
Tax withholdingCommon Stock 381 $127.03 $48,398.43
Disclosure

SEC source: 0000911916-19-000082 · edgar.xml · nonDerivative · entry 2

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,473

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
March 20, 2019 Filed Mar 22, 2019 20:14 UTC
Phipps Chad FSr. VP/Gen Counsel/Secretary
Exercise / conversionCommon Stock 1,331 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000082 · edgar.xml · nonDerivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,854

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 265 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan and pursuant to dividend reinvestment between October 31, 2018 and January 31, 2019.

Read SEC document
March 20, 2019 Filed Mar 22, 2019 20:14 UTC
Hanson Bryan CDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 7,872 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000080 · edgar.xml · derivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,872 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: Earned RSUs vested on March 20, 2019.

F3 · derivative.expiration_date: Earned RSUs vested on March 20, 2019.

Read SEC document
March 20, 2019 Filed Mar 22, 2019 20:14 UTC
Hanson Bryan CDirector · President and CEO
Tax withholdingCommon Stock 3,649 $127.03 $463,532.47
Disclosure

SEC source: 0000911916-19-000080 · edgar.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,438

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
March 20, 2019 Filed Mar 22, 2019 20:14 UTC
Hanson Bryan CDirector · President and CEO
Exercise / conversionCommon Stock 7,872 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000080 · edgar.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,087

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 20, 2019 Filed Mar 22, 2019 20:13 UTC
Florin Daniel PExec. VP, CFO
Exercise / conversionRestricted Stock Units · Derivative 2,551 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000078 · edgar.xml · derivative · entry 4

Florin Daniel P · CIK 0001402459 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,551 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: Earned RSUs vested on March 20, 2019.

F4 · derivative.expiration_date: Earned RSUs vested on March 20, 2019.

Read SEC document
March 20, 2019 Filed Mar 22, 2019 20:13 UTC
Florin Daniel PExec. VP, CFO
Tax withholdingCommon Stock 749 $127.03 $95,145.47
Disclosure

SEC source: 0000911916-19-000078 · edgar.xml · nonDerivative · entry 3

Florin Daniel P · CIK 0001402459 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,710

F2 · shares: Represents shares withheld by the Company to satisfy tax withholing oblications on the vesting of restricted stock units ("RSU").

Read SEC document
March 20, 2019 Filed Mar 22, 2019 20:13 UTC
Florin Daniel PExec. VP, CFO
Exercise / conversionCommon Stock 2,551 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000078 · edgar.xml · nonDerivative · entry 2

Florin Daniel P · CIK 0001402459 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,459

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 20, 2019 Filed Mar 22, 2019 20:12 UTC
Bruneau AureGroup President
Exercise / conversionRestricted Stock Units · Derivative 666 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000076 · edgar.xml · derivative · entry 3

Bruneau Aure · CIK 0001725831 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 666 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: Earned RSUs vested on March 20, 2019.

F3 · derivative.expiration_date: Earned RSUs vested on March 20, 2019.

Read SEC document
March 20, 2019 Filed Mar 22, 2019 20:12 UTC
Bruneau AureGroup President
Tax withholdingCommon Stock 163 $127.03 $20,705.89
Disclosure

SEC source: 0000911916-19-000076 · edgar.xml · nonDerivative · entry 2

Bruneau Aure · CIK 0001725831 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 757

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
March 20, 2019 Filed Mar 22, 2019 20:12 UTC
Bruneau AureGroup President
Exercise / conversionCommon Stock 666 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000076 · edgar.xml · nonDerivative · entry 1

Bruneau Aure · CIK 0001725831 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 920

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 12, 2019 Filed Mar 22, 2019 20:13 UTC
Florin Daniel PExec. VP, CFO
GiftCommon Stock 490 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000078 · edgar.xml · nonDerivative · entry 1

Florin Daniel P · CIK 0001402459 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,908

F1 · balance_after: Includes 72 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between June 30, 2018 and December 31, 2018.

Read SEC document
March 01, 2019 Filed Mar 4, 2019 21:32 UTC PurchaseCommon Stock 1,925 $125.52 $241,623.88
Disclosure

SEC source: 0000911916-19-000068 · edgar.xml · nonDerivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,925

Read SEC document
February 26, 2019 Filed Feb 28, 2019 21:30 UTC
Bruneau AureGroup President
GrantEmployee Stock Option (right to buy) · Derivative 10,446 $0.00 Strike: $123.73 $0.00
Disclosure

SEC source: 0000911916-19-000061 · edgar.xml · derivative · entry 1

Bruneau Aure · CIK 0001725831 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,446

Underlying: Common Stock · 10,446 shares

Expires 2029-02-26

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020.

Read SEC document
February 26, 2019 Filed Feb 28, 2019 21:33 UTC
Yi SangPresident, Asia Pacific
GrantEmployee Stock Option (right to buy) · Derivative 26,116 $0.00 Strike: $123.73 $0.00
Disclosure

SEC source: 0000911916-19-000067 · edgar.xml · derivative · entry 1

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,116

Underlying: Common Stock · 26,116 shares

Expires 2029-02-26

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020.

Read SEC document
February 26, 2019 Filed Feb 28, 2019 21:33 UTC
Tornos IvanGroup President, Orthopedics
GrantEmployee Stock Option (right to buy) · Derivative 40,045 $0.00 Strike: $123.73 $0.00
Disclosure

SEC source: 0000911916-19-000066 · edgar.xml · derivative · entry 1

Tornos Ivan · CIK 0001757216 · Group President, Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,045

Underlying: Common Stock · 40,045 shares

Expires 2029-02-26

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020.

Read SEC document
February 26, 2019 Filed Feb 28, 2019 21:32 UTC
Phipps Chad FSr. VP/Gen Counsel/Secretary
GrantEmployee Stock Option (right to buy) · Derivative 23,940 $0.00 Strike: $123.73 $0.00
Disclosure

SEC source: 0000911916-19-000065 · edgar.xml · derivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,940

Underlying: Common Stock · 23,940 shares

Expires 2029-02-26

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020.

Read SEC document
February 26, 2019 Filed Feb 28, 2019 21:32 UTC
Hanson Bryan CDirector · President and CEO
GrantEmployee Stock Option (right to buy) · Derivative 144,501 $0.00 Strike: $123.73 $0.00
Disclosure

SEC source: 0000911916-19-000064 · edgar.xml · derivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,501

Underlying: Common Stock · 144,501 shares

Expires 2029-02-26

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020.

Read SEC document
February 26, 2019 Filed Feb 28, 2019 21:31 UTC
Florin Daniel PExec. VP, CFO
GrantEmployee Stock Option (right to buy) · Derivative 40,045 $0.00 Strike: $123.73 $0.00
Disclosure

SEC source: 0000911916-19-000063 · edgar.xml · derivative · entry 1

Florin Daniel P · CIK 0001402459 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,045

Underlying: Common Stock · 40,045 shares

Expires 2029-02-26

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020.

Read SEC document
February 26, 2019 Filed Feb 28, 2019 21:30 UTC
Deltort DidierPresident, EMEA
GrantEmployee Stock Option (right to buy) · Derivative 24,375 $0.00 Strike: $123.73 $0.00
Disclosure

SEC source: 0000911916-19-000062 · edgar.xml · derivative · entry 1

Deltort Didier · CIK 0001749419 · President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,375

Underlying: Common Stock · 24,375 shares

Expires 2029-02-26

F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020.

Read SEC document
February 15, 2019 Filed Feb 19, 2019 11:03 UTC PurchaseCommon Stock 500 $123.28 $61,637.65
Disclosure

SEC source: 0000911916-19-000036 · edgar.xml · nonDerivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,400

Read SEC document
February 15, 2019 Filed Feb 20, 2019 21:36 UTC
Bruneau AureGroup President
GrantRestricted Stock Units · Derivative 666 $0.00 $0.00
Disclosure

SEC source: 0000911916-19-000047 · edgar.xml · derivative · entry 1

Bruneau Aure · CIK 0001725831 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 666

Underlying: Common Stock · 666 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 666 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on March 20, 2019.

F3 · derivative.expiration_date: Earned RSUs will vest on March 20, 2019.

F2 · derivative.underlying_shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 666 RSUs.

F2 · balance_after: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 666 RSUs.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.